Glypican-3–Targeted 89Zr PET Imaging of Hepatocellular Carcinoma

Jonathan G. Sham; Forrest M. Kievit; John R. Grierson; Robert S. Miyaoka; Matthew M. Yeh; Miqin Zhang; Raymond S. Yeung; Satoshi Minoshima; James O. Park

doi:10.2967/jnumed.113.132118

Research ArticleBasic Science Investigations

Glypican-3–Targeted ⁸⁹Zr PET Imaging of Hepatocellular Carcinoma

Jonathan G. Sham, Forrest M. Kievit, John R. Grierson, Robert S. Miyaoka, Matthew M. Yeh, Miqin Zhang, Raymond S. Yeung, Satoshi Minoshima and James O. Park

Journal of Nuclear Medicine May 2014, 55 (5) 799-804; DOI: https://doi.org/10.2967/jnumed.113.132118

Jonathan G. Sham

1Department of Surgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Forrest M. Kievit

2Department of Neurosurgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John R. Grierson

3Department of Radiology, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert S. Miyaoka

3Department of Radiology, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthew M. Yeh

4Department of Pathology, University of Washington, Seattle, Washington; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Miqin Zhang

5Department of Materials Science and Engineering, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raymond S. Yeung

1Department of Surgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Satoshi Minoshima

3Department of Radiology, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James O. Park

1Department of Surgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 55, Issue 5

May 1, 2014

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Glypican-3–Targeted 89Zr PET Imaging of Hepatocellular Carcinoma

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Glypican-3–Targeted ⁸⁹Zr PET Imaging of Hepatocellular Carcinoma

Jonathan G. Sham, Forrest M. Kievit, John R. Grierson, Robert S. Miyaoka, Matthew M. Yeh, Miqin Zhang, Raymond S. Yeung, Satoshi Minoshima, James O. Park

Journal of Nuclear Medicine May 2014, 55 (5) 799-804; DOI: 10.2967/jnumed.113.132118

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Glypican-3–Targeted ⁸⁹Zr PET Imaging of Hepatocellular Carcinoma

Jonathan G. Sham, Forrest M. Kievit, John R. Grierson, Robert S. Miyaoka, Matthew M. Yeh, Miqin Zhang, Raymond S. Yeung, Satoshi Minoshima, James O. Park

Journal of Nuclear Medicine May 2014, 55 (5) 799-804; DOI: 10.2967/jnumed.113.132118

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Glypican-3–Targeted ⁸⁹Zr PET Imaging of Hepatocellular Carcinoma: Where Antibody Imaging Dares to Tread
This Month in JNM

PubMed
Google Scholar

Cited By...

Glypican-3-Targeted 227Th {alpha}-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma
Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer
Pretargeted Immuno-PET: Overcoming Limitations of Space and Time
Glypican-3-Targeting F(ab')2 for 89Zr PET of Hepatocellular Carcinoma
Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma: Where Antibody Imaging Dares to Tread

Google Scholar

Keywords

hepatocellular carcinoma
89Zr
glypican 3
liver
PET

Main menu

User menu

Search

Glypican-3–Targeted ⁸⁹Zr PET Imaging of Hepatocellular Carcinoma

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords